GlassScriptPhysician profile
Senja Tomovic
NPI 1255568846
$15,600.77
in general payments reported to CMS, 2019-2025
21 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,789 · 2020: $358 · 2021: $3,488 · 2022: $1,039 · 2023: $7,068 · 2024: $1,448 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,656 · Food and Beverage: $1,211 · Travel and Lodging: $1,024 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,656.25 |
| Food and Beverage | $1,211.20 |
| Travel and Lodging | $1,024.28 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $13,738.62 | 2019-2024 | Inspire |
| Optinose US, INC. | $539.53 | 2019-2024 | |
| Medtronic, INC. | $174.36 | 2021-2025 | Propel, Nim Vital |
| Hologic Sales and Service, LLC | $168.32 | 2023-2025 | Coolseal Generator |
| Integra Lifesciences Corporation | $148.12 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Stryker Corporation | $140.20 | 2019-2025 | Medline Industries, INC. |
| Regeneron Healthcare Solutions, INC. | $137.16 | 2020-2021 | |
| Axogen | $77.46 | 2019-2021 | |
| Glaxosmithkline, LLC. | $72.15 | 2022 | |
| Spirair, INC. | $59.21 | 2025 | |
| Genzyme Corporation | $56.75 | 2022 | |
| Davol INC. | $43.40 | 2021 | |
| Intersect Ent, INC. | $42.06 | 2021 | |
| Alk-Abello, INC | $37.98 | 2019 | |
| Amgen INC. | $34.00 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atos Medical INC | $33.47 | 2019 | |
| Acclarent, INC | $32.45 | 2022-2023 | Acclarent Aera |
| Aerin Medical INC. | $22.22 | 2022 | |
| Olympus America INC. | $15.07 | 2019 | |
| Merck Sharp & Dohme LLC | $14.99 | 2021 | |
| Covidien LP | $13.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Senja Tomovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.